Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. COO
2. ORCL
3. ADBE
4. CHWY
5. NVDA
6. AVAV
7. RH
8. SPY
9. MSFT
10. AAPL

Go back to Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study
(NASDAQ: EDSA) Delayed: 4.66 --0 (-0%)
Previous Close $4.66    52 Week High $ 
Open $4.66    52 Week Low $ 
Day High $4.66    P/E N/A 
Day Low $4.66    EPS $ 
Volume 151